id	sid	eid	entity	type
amwa-224	1	1	n2 / 2023	PRODUCT
amwa-224	1	2	2023	CARDINAL
amwa-224	1	3	american	NORP
amwa-224	3	1	issn 2163-5315	PERSON
amwa-224	4	1	3	CARDINAL
amwa-224	4	2	1	CARDINAL
amwa-224	4	3	2	CARDINAL
amwa-224	4	4	3	CARDINAL
amwa-224	4	5	2	CARDINAL
amwa-224	8	1	first	ORDINAL
amwa-224	8	2	paul ehrlich	PERSON
amwa-224	8	3	the early 1900s	DATE
amwa-224	8	4	the 1940s	DATE
amwa-224	8	5	first	ORDINAL
amwa-224	9	1	the 1970s	DATE
amwa-224	9	2	2	CARDINAL
amwa-224	9	3	first	ORDINAL
amwa-224	10	1	recent decades	DATE
amwa-224	10	2	13	CARDINAL
amwa-224	10	3	mab	PERSON
amwa-224	10	4	1	CARDINAL
amwa-224	11	1	adc	PERSON
amwa-224	11	2	1	CARDINAL
amwa-224	11	3	2	CARDINAL
amwa-224	11	4	3	CARDINAL
amwa-224	11	5	4	CARDINAL
amwa-224	11	6	5	CARDINAL
amwa-224	11	7	1	CARDINAL
amwa-224	12	1	adc	ORG
amwa-224	12	2	adc	PERSON
amwa-224	12	3	jason r. lewis	PERSON
amwa-224	12	4	pharmd	PERSON
amwa-224	12	5	mba	PERSON
amwa-224	12	6	nephi	ORG
amwa-224	12	7	ut antibody-drug	PERSON
amwa-224	12	8	1	CARDINAL
amwa-224	12	9	adc	PERSON
amwa-224	16	1	adc	ORG
amwa-224	21	1	1	CARDINAL
amwa-224	22	1	adc	ORG
amwa-224	22	2	1	CARDINAL
amwa-224	23	1	adc	ORG
amwa-224	23	2	design1,7,25,26	ORG
amwa-224	23	3	•	CARDINAL
amwa-224	23	4	•	CARDINAL
amwa-224	23	5	•	CARDINAL
amwa-224	23	6	•	CARDINAL
amwa-224	23	7	•	CARDINAL
amwa-224	23	8	•	CARDINAL
amwa-224	23	9	• long pk	QUANTITY
amwa-224	23	10	half	CARDINAL
amwa-224	23	11	•	CARDINAL
amwa-224	23	12	•	CARDINAL
amwa-224	23	13	•	CARDINAL
amwa-224	23	14	•	CARDINAL
amwa-224	23	15	•	CARDINAL
amwa-224	23	16	•	CARDINAL
amwa-224	23	17	•	CARDINAL
amwa-224	23	18	•	CARDINAL
amwa-224	23	19	•	CARDINAL
amwa-224	23	20	•	CARDINAL
amwa-224	23	21	•	CARDINAL
amwa-224	23	22	•	CARDINAL
amwa-224	23	23	•	CARDINAL
amwa-224	23	24	•	CARDINAL
amwa-224	23	25	•	CARDINAL
amwa-224	23	26	•	CARDINAL
amwa-224	23	27	•	CARDINAL
amwa-224	23	28	•	CARDINAL
amwa-224	23	29	•	CARDINAL
amwa-224	23	30	tubulysin	GPE
amwa-224	23	31	•	CARDINAL
amwa-224	23	32	•	CARDINAL
amwa-224	23	33	•	CARDINAL
amwa-224	23	34	•	CARDINAL
amwa-224	23	35	•	CARDINAL
amwa-224	23	36	•	CARDINAL
amwa-224	23	37	dm4	PERSON
amwa-224	23	38	dxd	GPE
amwa-224	23	39	fab	ORG
amwa-224	23	40	fc	ORG
amwa-224	23	41	monomethyl auristatin	PERSON
amwa-224	23	42	mmaf	GPE
amwa-224	23	43	monomethyl auristatin	PERSON
amwa-224	23	44	4-(n-maleimidomethyl)cyclohexane-1	QUANTITY
amwa-224	25	1	half	CARDINAL
amwa-224	26	1	5	CARDINAL
amwa-224	26	2	ige	PERSON
amwa-224	26	3	igg	ORG
amwa-224	26	4	igg	ORG
amwa-224	26	5	fc	NORP
amwa-224	26	6	adc	GPE
amwa-224	27	1	adc	GPE
amwa-224	27	2	adc	GPE
amwa-224	28	1	igg	ORG
amwa-224	28	2	80-100	CARDINAL
amwa-224	28	3	32-40	CARDINAL
amwa-224	28	4	36	CARDINAL
amwa-224	29	1	0 to 8	CARDINAL
amwa-224	29	2	adc	ORG
amwa-224	29	3	adc	PERSON
amwa-224	29	4	properties.1,37,41	ORG
amwa-224	29	5	1	CARDINAL
amwa-224	29	6	2	CARDINAL
amwa-224	29	7	3	CARDINAL
amwa-224	29	8	4	CARDINAL
amwa-224	29	9	5	CARDINAL
amwa-224	29	10	6	CARDINAL
amwa-224	29	11	technology.1,21,45,46	PERSON
amwa-224	29	12	thiomab	PERSON
amwa-224	29	13	antibody.47 drug conjugates	ORG
amwa-224	29	14	thiomab	PERSON
amwa-224	29	15	thiomab-drug	PERSON
amwa-224	29	16	indexes.46	LOC
amwa-224	29	17	4	CARDINAL
amwa-224	30	1	ch2	ORG
amwa-224	30	2	igg antibodies.52	ORG
amwa-224	31	1	adc	GPE
amwa-224	31	2	the cytotoxic drug	ORG
amwa-224	32	1	adc	PERSON
amwa-224	32	2	adc	PERSON
amwa-224	32	3	site.2,24	NORP
amwa-224	32	4	adc	GPE
amwa-224	32	5	2	CARDINAL
amwa-224	32	6	3	CARDINAL
amwa-224	32	7	site.24,28,54	NORP
amwa-224	33	1	half	CARDINAL
amwa-224	36	1	adc	GPE
amwa-224	36	2	succinimidyl-4-(n-maleimidomethyl	PERSON
amwa-224	36	3	maleimdopropionyl	PERSON
amwa-224	36	4	100 to 1,000	CARDINAL
amwa-224	36	5	2	CARDINAL
amwa-224	36	6	1	CARDINAL
amwa-224	36	7	2	CARDINAL
amwa-224	36	8	maytansinoids	ORG
amwa-224	36	9	first	ORDINAL
amwa-224	36	10	micromonospora echinospora	PERSON
amwa-224	36	11	mid1980s	GPE
amwa-224	36	12	dar	GPE
amwa-224	38	1	duocarmycin	PERSON
amwa-224	38	2	64	CARDINAL
amwa-224	38	3	pbd	ORG
amwa-224	38	4	68	CARDINAL
amwa-224	38	5	pbd	PRODUCT
amwa-224	38	6	death.28,69,70	NORP
amwa-224	38	7	pbd	ORG
amwa-224	39	1	adc	ORG
amwa-224	39	2	monomethyl auristatin e	PERSON
amwa-224	39	3	monomethyl auristatin	PERSON
amwa-224	39	4	80	CARDINAL
amwa-224	39	5	african	NORP
amwa-224	40	1	adc	GPE
amwa-224	40	2	2 thiomethyl	QUANTITY
amwa-224	40	3	myxobacteria	NORP
amwa-224	40	4	angiococcus disciformis	PERSON
amwa-224	40	5	the last several decades	DATE
amwa-224	40	6	15%	PERCENT
amwa-224	40	7	2000	DATE
amwa-224	40	8	55%	PERCENT
amwa-224	40	9	2018.89	CARDINAL
amwa-224	41	1	first	ORDINAL
amwa-224	41	2	2000	DATE
amwa-224	41	3	the last few decades	DATE
amwa-224	42	1	2022	CARDINAL
amwa-224	42	2	12	CARDINAL
amwa-224	42	3	9	CARDINAL
amwa-224	42	4	80	CARDINAL
amwa-224	44	1	2	CARDINAL
amwa-224	44	2	mbc	NORP
amwa-224	44	3	95	CARDINAL
amwa-224	44	4	mbc	GPE
amwa-224	45	1	mbc	NORP
amwa-224	45	2	adc	ORG
amwa-224	46	1	the last 5 years alone	DATE
amwa-224	46	2	39	CARDINAL
amwa-224	46	3	over 19	CARDINAL
amwa-224	46	4	adc	PERSON
amwa-224	48	1	yuqian	NORP
amwa-224	48	2	ma	PERSON
amwa-224	51	1	1	CARDINAL
amwa-224	52	1	fu z	PERSON
amwa-224	52	2	li s	PERSON
amwa-224	52	3	han s	ORG
amwa-224	52	4	zhang y. antibody drug	PERSON
amwa-224	54	1	2022;7(1):93	CARDINAL
amwa-224	54	2	doi:10.1038	ORG
amwa-224	55	1	feld	GPE
amwa-224	55	2	barta	PERSON
amwa-224	55	3	zhou y, verma ak.	PERSON
amwa-224	57	1	2013;4(3):397-412	CARDINAL
amwa-224	57	2	10.18632/	CARDINAL
amwa-224	57	3	3	CARDINAL
amwa-224	58	1	devita vt jr, chu e.	PERSON
amwa-224	60	1	2008;68(21):8643-8653	DATE
amwa-224	61	1	doi:10.1158/0008-5472.can-07-6611 4	ORG
amwa-224	64	1	5	CARDINAL
amwa-224	64	2	tong jtw	PERSON
amwa-224	64	3	harris pwr	PERSON
amwa-224	64	4	ma	PERSON
amwa-224	64	5	kavianinia i.	PERSON
amwa-224	64	6	fda	ORG
amwa-224	66	1	2021;26(19):5847	ORDINAL
amwa-224	67	1	molecules26195847 6	FAC
amwa-224	68	1	weiss d	ORG
amwa-224	68	2	girish s	PERSON
amwa-224	68	3	trastuzumab	PERSON
amwa-224	68	4	2	CARDINAL
amwa-224	69	1	clin	PERSON
amwa-224	70	1	2011;17(20):6437-6447	ORG
amwa-224	71	1	dean aq	PERSON
amwa-224	71	2	luo s	PERSON
amwa-224	71	3	twomey jd	PERSON
amwa-224	71	4	zhang b.	PERSON
amwa-224	73	1	2021;13(1):1951427	CARDINAL
amwa-224	74	1	8	CARDINAL
amwa-224	76	1	seagen inc.	ORG
amwa-224	76	2	2022	CARDINAL
amwa-224	77	1	november 1	DATE
amwa-224	77	2	2022	CARDINAL
amwa-224	78	1	https://www.adcetrispro.com/ 9	DATE
amwa-224	79	1	pfizer inc.	ORG
amwa-224	79	2	2018	DATE
amwa-224	80	1	november 1	DATE
amwa-224	80	2	2022	CARDINAL
amwa-224	81	1	https://besponsa.pfizerpro.com/ 10	DATE
amwa-224	83	1	glaxosmithkline	PERSON
amwa-224	83	2	2022	CARDINAL
amwa-224	84	1	november 1	DATE
amwa-224	84	2	2022	CARDINAL
amwa-224	85	1	pdf	ORG
amwa-224	87	1	2022	CARDINAL
amwa-224	88	1	november 1	DATE
amwa-224	88	2	2022	CARDINAL
amwa-224	89	1	12	CARDINAL
amwa-224	90	1	pfizer inc.	ORG
amwa-224	90	2	2021	CARDINAL
amwa-224	91	1	november 1	DATE
amwa-224	91	2	2022	CARDINAL
amwa-224	92	1	13	CARDINAL
amwa-224	93	1	genentech inc.	ORG
amwa-224	93	2	2020	DATE
amwa-224	94	1	november 1	DATE
amwa-224	94	2	2022	CARDINAL
amwa-224	95	1	14	CARDINAL
amwa-224	97	1	adc therapeutics sa	ORG
amwa-224	98	1	2022	CARDINAL
amwa-224	99	1	november 1	DATE
amwa-224	99	2	2022	CARDINAL
amwa-224	101	1	15	CARDINAL
amwa-224	102	1	immunogen, inc.	ORG
amwa-224	102	2	2022	CARDINAL
amwa-224	103	1	november 23	DATE
amwa-224	103	2	2022	CARDINAL
amwa-224	104	1	16	CARDINAL
amwa-224	106	1	daiichi sankyo, inc.	ORG
amwa-224	106	2	2022	CARDINAL
amwa-224	107	1	november 1	DATE
amwa-224	107	2	2022	CARDINAL
amwa-224	107	3	17	CARDINAL
amwa-224	109	1	genentech inc.	ORG
amwa-224	109	2	2022	CARDINAL
amwa-224	110	1	november 1	DATE
amwa-224	110	2	2022	CARDINAL
amwa-224	111	1	18	CARDINAL
amwa-224	112	1	seagen inc.	ORG
amwa-224	112	2	2022	CARDINAL
amwa-224	113	1	november 1	DATE
amwa-224	113	2	2022	DATE
amwa-224	114	1	https://www.padcev.com/hcp 19	DATE
amwa-224	114	2	tivdak	ORG
amwa-224	115	1	seagen inc.	ORG
amwa-224	115	2	2022	CARDINAL
amwa-224	116	1	november 1	DATE
amwa-224	116	2	2022	DATE
amwa-224	117	1	20	CARDINAL
amwa-224	119	1	gilead sciences, inc.	ORG
amwa-224	119	2	2022	CARDINAL
amwa-224	120	1	november 1	DATE
amwa-224	120	2	2022	CARDINAL
amwa-224	121	1	21	CARDINAL
amwa-224	122	1	hafeez u	PERSON
amwa-224	122	2	parakh s	PERSON
amwa-224	122	3	scott am	PERSON
amwa-224	125	1	2020;25(20):4764	CARDINAL
amwa-224	126	1	molecules25204764	NORP
amwa-224	127	1	tarantino p	PERSON
amwa-224	128	1	curr	PERSON
amwa-224	128	2	2022;24(7):809-817	CARDINAL
amwa-224	130	1	gm	ORG
amwa-224	130	2	adc	GPE
amwa-224	132	1	2018;181:126-142	CARDINAL
amwa-224	133	1	doi:10.1016/j.pharmthera.2017.07.013	LOC
amwa-224	133	2	24	CARDINAL
amwa-224	134	1	peters c	PERSON
amwa-224	134	2	brown s. antibody-drug	PERSON
amwa-224	135	1	biosci	GPE
amwa-224	135	2	2015;35(4):e00225	CARDINAL
amwa-224	136	1	doi:10.1042/ bsr20150089	PERSON
amwa-224	136	2	25	CARDINAL
amwa-224	137	1	singh	GPE
amwa-224	137	2	shankar r. antibody drug conjugates	PERSON
amwa-224	139	1	2021;340:1-34	ORG
amwa-224	140	1	doi:10.1016	GPE
amwa-224	141	1	26	CARDINAL
amwa-224	142	1	de la torre bg	ORG
amwa-224	142	2	albericio f. linkers	PERSON
amwa-224	144	1	2022;14(2):396	CARDINAL
amwa-224	146	1	zhang j	PERSON
amwa-224	146	2	wang j	PERSON
amwa-224	146	3	jin m. cysteine	PERSON
amwa-224	147	1	bioconjug chem	PERSON
amwa-224	148	1	2021;32(8):1525-1534	CARDINAL
amwa-224	149	1	28	CARDINAL
amwa-224	150	1	beck	PERSON
amwa-224	151	1	nat rev drug	PERSON
amwa-224	152	1	2017;16(5):315-337	CARDINAL
amwa-224	153	1	29	CARDINAL
amwa-224	154	1	damelin m	PERSON
amwa-224	154	2	zhong w	PERSON
amwa-224	154	3	myers j	PERSON
amwa-224	154	4	sapra	PERSON
amwa-224	156	1	2015;32(11):3494-3507	DATE
amwa-224	156	2	015-1624	CARDINAL
amwa-224	157	1	carter pj	PERSON
amwa-224	157	2	senter pd.	ORG
amwa-224	158	1	j. 2008;14(3):154-169	PERSON
amwa-224	159	1	31	CARDINAL
amwa-224	162	1	2013;1045:71-100	CARDINAL
amwa-224	163	1	1-62703541-5_5 32	CARDINAL
amwa-224	164	1	wang w	PERSON
amwa-224	164	2	wang eq	PERSON
amwa-224	165	1	clin pharmacol	ORG
amwa-224	166	1	2008;84(5):548-558	CARDINAL
amwa-224	167	1	doi:10.1038	ORG
amwa-224	167	2	33	CARDINAL
amwa-224	167	3	brun mp	ORG
amwa-224	167	4	lazo l.	PERSON
amwa-224	169	1	2013;1045:173-187	CARDINAL
amwa-224	171	1	gaza-bulseco g	ORG
amwa-224	171	2	liu h.	PERSON
amwa-224	173	1	2009;81(15):6449-6457	DATE
amwa-224	174	1	ac900815z 35	DATE
amwa-224	175	1	adumeau p	PERSON
amwa-224	175	2	sharma sk	PERSON
amwa-224	175	3	zeglis bm	PERSON
amwa-224	176	1	1	CARDINAL
amwa-224	178	1	2016;18(1):1	CARDINAL
amwa-224	180	1	ea	CARDINAL
amwa-224	183	1	1994;31(3):169-217	CARDINAL
amwa-224	185	1	benhar i. antibody-targeted	PERSON
amwa-224	187	1	2015;18:36-46	DATE
amwa-224	187	2	doi:10.1016	GPE
amwa-224	188	1	boylan nj	PERSON
amwa-224	188	2	zhou w	PERSON
amwa-224	188	3	rj	GPE
amwa-224	188	4	tolbert tj	PERSON
amwa-224	188	5	wolfe jl	PERSON
amwa-224	189	1	fc	NORP
amwa-224	191	1	2013;24(6):10081016	DATE
amwa-224	192	1	39	CARDINAL
amwa-224	193	1	wakankar aa	PERSON
amwa-224	193	2	feeney mb	PERSON
amwa-224	193	3	rivera j	PERSON
amwa-224	194	1	bioconjug chem	PERSON
amwa-224	195	1	2010;21(9):1588-1595	ORG
amwa-224	196	1	40	CARDINAL
amwa-224	197	1	kwon h	GPE
amwa-224	197	2	jochheim cm	PERSON
amwa-224	197	3	atkins wm	PERSON
amwa-224	197	4	fc	NORP
amwa-224	199	1	2012;4(3):362-372	CARDINAL
amwa-224	200	1	hallam tj	PERSON
amwa-224	202	1	10.1021	CARDINAL
amwa-224	202	2	42	CARDINAL
amwa-224	203	1	hamblett kj	PERSON
amwa-224	203	2	senter pd	GPE
amwa-224	203	3	chace df	PERSON
amwa-224	204	1	clin	PERSON
amwa-224	205	1	2004;10(20):7063-7070	CARDINAL
amwa-224	207	1	0789 43	DATE
amwa-224	208	1	reema	PERSON
amwa-224	208	2	nakakido m	ORG
amwa-224	208	3	tsumoto k. improvement	PERSON
amwa-224	209	1	biochem biophys	PERSON
amwa-224	209	2	2018;15:81-85	DATE
amwa-224	209	3	doi:10.1016/j.bbrep.2018.07.005 44	EVENT
amwa-224	210	1	shen bq	PERSON
amwa-224	213	1	2012;30(2):184	CARDINAL
amwa-224	214	1	doi:10.1038	ORG
amwa-224	215	1	chen xn	PERSON
amwa-224	215	2	nguyen m	PERSON
amwa-224	215	3	jacobson f	PERSON
amwa-224	215	4	ouyang j. charge-based	PERSON
amwa-224	216	1	mabs	PERSON
amwa-224	217	1	2009;1(6):563-571	CARDINAL
amwa-224	219	1	junutula jr, raab h	PERSON
amwa-224	219	2	clark s	PERSON
amwa-224	220	1	nat biotechnol	PERSON
amwa-224	221	1	2008;26(8):925-932	CARDINAL
amwa-224	221	2	doi:10.1038	ORG
amwa-224	221	3	nbt.1480 47	DATE
amwa-224	222	1	zhou q.	PERSON
amwa-224	222	2	adc	PERSON
amwa-224	224	1	2017;5(4):64	CARDINAL
amwa-224	225	1	48	CARDINAL
amwa-224	226	1	walsh sj	PERSON
amwa-224	226	2	bargh jd	PERSON
amwa-224	226	3	dannheim fm	PERSON
amwa-224	228	1	2021;50:1305-1353	CARDINAL
amwa-224	229	1	10.1039	CARDINAL
amwa-224	229	2	49	DATE
amwa-224	230	1	axup jy	PERSON
amwa-224	231	1	sci usa	ORG
amwa-224	232	1	2012;109(40):16101-16106	DATE
amwa-224	233	1	50	DATE
amwa-224	236	1	sci usa.	ORG
amwa-224	240	1	kim	PERSON
amwa-224	240	2	kim km	PERSON
amwa-224	241	1	biomol	PERSON
amwa-224	241	2	seoul	GPE
amwa-224	242	1	2015;23(6):493-509	CARDINAL
amwa-224	243	1	doi:10.4062/	ORG
amwa-224	243	2	52	CARDINAL
amwa-224	244	1	agarwal p	ORG
amwa-224	245	1	bioconjug chem	PERSON
amwa-224	246	1	2015;26(2):176	CARDINAL
amwa-224	247	1	53	CARDINAL
amwa-224	248	1	cao yj	PERSON
amwa-224	248	2	wu kl	PERSON
amwa-224	250	1	2021;11(18):9107-9117	CARDINAL
amwa-224	253	1	balendiran gk	PERSON
amwa-224	253	2	dabur r	PERSON
amwa-224	253	3	fraser d.	PERSON
amwa-224	255	1	2004;22(6):343-352	CARDINAL
amwa-224	256	1	cbf.1149 55	DATE
amwa-224	257	1	sanderson rj	PERSON
amwa-224	257	2	hering ma	PERSON
amwa-224	257	3	james sf	PERSON
amwa-224	258	1	anti-cd30	NORP
amwa-224	259	1	clin	PERSON
amwa-224	260	1	2005;11(2	CARDINAL
amwa-224	260	2	1):843-852	CARDINAL
amwa-224	261	1	56	DATE
amwa-224	262	1	erickson hk	PERSON
amwa-224	262	2	park pu	PERSON
amwa-224	262	3	widdison wc	PERSON
amwa-224	265	1	doi:10.1158/00085472.can-05-4489 57	ORG
amwa-224	266	1	pietersz ga	PERSON
amwa-224	266	2	krauer k. antibody-	PERSON
amwa-224	268	1	1994;2(3):183-215	CARDINAL
amwa-224	269	1	58	CARDINAL
amwa-224	272	1	2015;67(2	CARDINAL
amwa-224	272	2	doi:10.1016	NORP
amwa-224	272	3	59	CARDINAL
amwa-224	273	1	walker s	PERSON
amwa-224	273	2	landovitz	PERSON
amwa-224	273	3	wd	GPE
amwa-224	273	4	ga	ORG
amwa-224	273	5	kahne d. cleavage	PERSON
amwa-224	273	6	sci usa	ORG
amwa-224	274	1	1992;89(10):4608-4612	CARDINAL
amwa-224	275	1	60	CARDINAL
amwa-224	276	1	elmroth k	PERSON
amwa-224	276	2	ismail ih	PERSON
amwa-224	276	3	gamma1	PERSON
amwa-224	278	1	2003;2(4):363-374	CARDINAL
amwa-224	278	2	doi:10.1016	GPE
amwa-224	279	1	zhao h	PERSON
amwa-224	279	2	hudson r	PERSON
amwa-224	279	3	tong xm	PERSON
amwa-224	279	4	wang mh.	PERSON
amwa-224	280	1	today	DATE
amwa-224	281	1	2021;26(8):1857-1874	DATE
amwa-224	282	1	doi:10.1016	GPE
amwa-224	283	1	hanka lj	PERSON
amwa-224	283	2	dietz	PERSON
amwa-224	283	3	kuentzel sl	PERSON
amwa-224	283	4	martin	PERSON
amwa-224	284	1	nsc-298223	DATE
amwa-224	286	1	tokyo	GPE
amwa-224	287	1	1978;31(12):1211-1217	CARDINAL
amwa-224	288	1	doi:10.7164	ORG
amwa-224	288	2	63	CARDINAL
amwa-224	289	1	menderes g	PERSON
amwa-224	292	1	2017;146(1):179	CARDINAL
amwa-224	292	2	10.1016/j.ygyno.2017.04.023	MONEY
amwa-224	293	1	64	DATE
amwa-224	294	1	boger dl	PERSON
amwa-224	296	1	acc chem res	ORG
amwa-224	297	1	1995;28(1):20-29	DATE
amwa-224	299	1	gerratana b. biosynthesis	PERSON
amwa-224	301	1	2012;32(2):254-293	CARDINAL
amwa-224	302	1	66	CARDINAL
amwa-224	303	1	ac	ORG
amwa-224	303	2	levy jn	PERSON
amwa-224	303	3	masterson la	PERSON
amwa-224	305	1	2016;7(11):983	CARDINAL
amwa-224	305	2	987	CARDINAL
amwa-224	306	1	10.1021	CARDINAL
amwa-224	307	1	67	CARDINAL
amwa-224	308	1	tendler md	GPE
amwa-224	308	2	korman s. '	PERSON
amwa-224	311	1	68	CARDINAL
amwa-224	312	1	leimgruber w	PERSON
amwa-224	312	2	schenker f	PERSON
amwa-224	312	3	karr	PERSON
amwa-224	312	4	berger j.	PERSON
amwa-224	314	1	1965;87(24):5791-5793	CARDINAL
amwa-224	315	1	69	CARDINAL
amwa-224	316	1	hartley ja	PERSON
amwa-224	316	2	flynn mj	PERSON
amwa-224	316	3	bingham jp	PERSON
amwa-224	317	1	sg3199	GPE
amwa-224	317	2	pbd	ORG
amwa-224	318	1	sci rep	ORG
amwa-224	318	2	2018;8(1):10479	CARDINAL
amwa-224	319	1	4 70	CARDINAL
amwa-224	320	1	w	GPE
amwa-224	320	2	alderuccio jp	PERSON
amwa-224	320	3	loncastuximab	PERSON
amwa-224	320	4	2	CARDINAL
amwa-224	322	1	2021;22(6):790-800	CARDINAL
amwa-224	323	1	doi:10.1016	GPE
amwa-224	323	2	71	CARDINAL
amwa-224	324	1	wani mc	PERSON
amwa-224	324	2	cook ce	PERSON
amwa-224	324	3	palmer kh	PERSON
amwa-224	324	4	mcphail	PERSON
amwa-224	324	5	ga	ORG
amwa-224	325	1	i.	PERSON
amwa-224	325	2	1,2	CARDINAL
amwa-224	327	1	1966;88(16):3888-3890	CARDINAL
amwa-224	328	1	72	DATE
amwa-224	329	1	li w	PERSON
amwa-224	329	2	veale kh	PERSON
amwa-224	329	3	qiu q	PERSON
amwa-224	331	1	2019;10(10):1386-1392	CARDINAL
amwa-224	332	1	73	CARDINAL
amwa-224	333	1	hsiang yh	PERSON
amwa-224	333	2	hecht s	PERSON
amwa-224	333	3	liu lf	PERSON
amwa-224	334	1	i. j biol chem	PERSON
amwa-224	335	1	1985;260(27):14873-14878	DATE
amwa-224	336	1	doi:10.1016	PERSON
amwa-224	337	1	ogitani y	PERSON
amwa-224	337	2	aida t	PERSON
amwa-224	337	3	hagihara k	PERSON
amwa-224	337	4	ds-8201a	LOC
amwa-224	338	1	clin	PERSON
amwa-224	339	1	2016;22(20):5097-5108	CARDINAL
amwa-224	340	1	doi:10.1158/1078-0432.ccr-15-2822 75	PERSON
amwa-224	341	1	goldenberg dm	PERSON
amwa-224	341	2	sharkey rm	PERSON
amwa-224	342	1	mabs	PERSON
amwa-224	343	1	2019;11(6):987-995	CARDINAL
amwa-224	344	1	420862.2019.1632115 76	DATE
amwa-224	345	1	senter pd	ORG
amwa-224	345	2	sievers el	GPE
amwa-224	347	1	nat biotechnol	ORG
amwa-224	348	1	2012;30(7):631-637	CARDINAL
amwa-224	349	1	doi:10.1038/nbt.2289 77	ORG
amwa-224	350	1	pettit gr	PERSON
amwa-224	353	1	1987;109(22):6883-6885	DATE
amwa-224	354	1	ja00256a070 78	DATE
amwa-224	355	1	bai	ORG
amwa-224	355	2	pettit gr	PERSON
amwa-224	355	3	hamel e. dolastatin 10	PERSON
amwa-224	358	1	1990;39(12):1941-1949	DATE
amwa-224	359	1	2952(90)90613	CARDINAL
amwa-224	359	2	79	CARDINAL
amwa-224	360	1	bai rl	PERSON
amwa-224	360	2	pettit gr	PERSON
amwa-224	360	3	hamel e.	PERSON
amwa-224	360	4	10	CARDINAL
amwa-224	361	1	biochem pharmacol	ORG
amwa-224	362	1	1990;40(8):1859-1864	DATE
amwa-224	364	1	waight ab	PERSON
amwa-224	364	2	bargsten k	FAC
amwa-224	364	3	steinmetz mo	ORG
amwa-224	365	1	anti-mitotics	NORP
amwa-224	366	1	plos one	PERSON
amwa-224	367	1	2016;11(8):e0160890	PRODUCT
amwa-224	367	2	10.1371	CARDINAL
amwa-224	367	3	81	DATE
amwa-224	368	1	kupchan sm	PERSON
amwa-224	368	2	komoda y	PERSON
amwa-224	368	3	branfman ar	PERSON
amwa-224	369	1	maytansinoids	NORP
amwa-224	370	1	ansa	NORP
amwa-224	372	1	1977;42(14):2349-2357	CARDINAL
amwa-224	373	1	82	CARDINAL
amwa-224	374	1	lambert jm	PERSON
amwa-224	374	2	chari rv	PERSON
amwa-224	376	1	2014;57(16):6949-6964	DATE
amwa-224	378	1	chen h,	PERSON
amwa-224	378	2	lin z	PERSON
amwa-224	378	3	miller dd	PERSON
amwa-224	378	4	li w. tubulin	PERSON
amwa-224	380	1	2017 aug 1;22(8):1281	DATE
amwa-224	381	1	10.3390	CARDINAL
amwa-224	382	1	28763044	DATE
amwa-224	383	1	84	CARDINAL
amwa-224	384	1	pegram md	PERSON
amwa-224	384	2	hamilton ep	PERSON
amwa-224	384	3	tan ar	PERSON
amwa-224	385	1	first	ORDINAL
amwa-224	385	2	1	CARDINAL
amwa-224	385	3	anti-her2	NORP
amwa-224	385	4	medi4276	ORG
amwa-224	387	1	2021;20(8):1442-1453	DATE
amwa-224	388	1	0014 85	CARDINAL
amwa-224	389	1	sasse	ORG
amwa-224	389	2	steinmetz h	ORG
amwa-224	389	3	heil j	PERSON
amwa-224	389	4	reichenbach h. tubulysins	PERSON
amwa-224	389	5	myxobacteria	PERSON
amwa-224	389	6	microtubuli	GPE
amwa-224	391	1	tokyo	GPE
amwa-224	392	1	2000;53(9):879-885	CARDINAL
amwa-224	393	1	86	CARDINAL
amwa-224	394	1	peters s	PERSON
amwa-224	394	2	jänne pa	PERSON
amwa-224	397	1	2021;11(4):810-814	DATE
amwa-224	398	1	doi:10.1158/2159	PERSON
amwa-224	398	2	8290.cd-21-0124 87	DATE
amwa-224	399	1	goldberg rm	PERSON
amwa-224	399	2	lenz hj	PERSON
amwa-224	400	1	2019	DATE
amwa-224	401	1	j clin	PERSON
amwa-224	402	1	2019;69(4):305-343	CARDINAL
amwa-224	404	1	88	CARDINAL
amwa-224	405	1	seebacher na	PERSON
amwa-224	405	2	stacy ae	PERSON
amwa-224	405	3	porter gm	PERSON
amwa-224	407	1	j exp clin	PERSON
amwa-224	410	1	oza c.	PERSON
amwa-224	412	1	pmc	ORG
amwa-224	412	2	2019	DATE
amwa-224	413	1	february 7	DATE
amwa-224	413	2	2022	DATE
amwa-224	416	1	90	CARDINAL
amwa-224	417	1	fda	ORG
amwa-224	417	2	2023	CARDINAL
amwa-224	419	1	october 30, 2019	DATE
amwa-224	420	1	february 19	DATE
amwa-224	420	2	2023	CARDINAL
amwa-224	421	1	91	CARDINAL
amwa-224	424	1	february 19	DATE
amwa-224	424	2	2023	CARDINAL
amwa-224	425	1	92	CARDINAL
amwa-224	426	1	fda	ORG
amwa-224	427	1	food and drug administration	ORG
amwa-224	428	1	may 11	DATE
amwa-224	428	2	2022	CARDINAL
amwa-224	429	1	february 19	DATE
amwa-224	429	2	2023	CARDINAL
amwa-224	430	1	fda	ORG
amwa-224	430	2	93	CARDINAL
amwa-224	431	1	fda	ORG
amwa-224	432	1	food and drug administration	ORG
amwa-224	433	1	january 15, 2021	DATE
amwa-224	434	1	february 19	DATE
amwa-224	434	2	2023	CARDINAL
amwa-224	435	1	94	CARDINAL
amwa-224	436	1	fda	ORG
amwa-224	437	1	food and drug administration	ORG
amwa-224	438	1	august 16	DATE
amwa-224	438	2	2022	CARDINAL
amwa-224	439	1	february 19	DATE
amwa-224	439	2	2023	CARDINAL
amwa-224	440	1	fda	ORG
amwa-224	440	2	95	CARDINAL
amwa-224	441	1	fda	ORG
amwa-224	442	1	food and drug administration	ORG
amwa-224	443	1	august 5	DATE
amwa-224	443	2	2022	CARDINAL
amwa-224	444	1	february 19	DATE
amwa-224	444	2	2023	CARDINAL
amwa-224	445	1	fda	ORG
amwa-224	445	2	96	CARDINAL
amwa-224	446	1	eiger	PERSON
amwa-224	446	2	saúde-conde	PERSON
amwa-224	450	1	yamashita t	GPE
amwa-224	452	1	2022;387(1):9-20	CARDINAL
amwa-224	453	1	abuhelwa	PERSON
amwa-224	453	2	nagasaka m.	PERSON
amwa-224	455	1	99	CARDINAL
amwa-224	456	1	mullin r. new day	PERSON
amwa-224	457	1	chemical & engineering news	ORG
amwa-224	458	1	may 15	DATE
amwa-224	458	2	2022	CARDINAL
amwa-224	459	1	november 23	DATE
amwa-224	459	2	2022	CARDINAL
amwa-224	463	1	https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-regular-approval-fam-trastuzumab-deruxtecan-nxki-breast-cancer https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-regular-approval-fam-trastuzumab-deruxtecan-nxki-breast-cancer https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-regular-approval-fam-trastuzumab-deruxtecan-nxki-breast-cancer https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-fam-trastuzumab-deruxtecan-nxki-her2-positive-gastric-adenocarcinomas https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-fam-trastuzumab-deruxtecan-nxki-her2-positive-gastric-adenocarcinomas https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-fam-trastuzumab-deruxtecan-nxki-her2-positive-gastric-adenocarcinomas https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-her2-mutant-non-small-cell-lung https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-her2-mutant-non-small-cell-lung https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-her2-mutant-non-small-cell-lung https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-her2-mutant-non-small-cell-lung	PERSON